{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:15:14Z","timestamp":1793780114015,"version":"4.6.1"},"reference-count":153,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacc.2023.01.049","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T14:00:05Z","timestamp":1681912805000},"page":"1810-1834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":770,"title":["Heart\u00a0Failure With Preserved Ejection\u00a0Fraction"],"prefix":"10.1016","volume":"81","author":[{"given":"Barry A.","family":"Borlaug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2023.01.049_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.01.049_bib2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/eurheartj\/ehab911","article-title":"Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality","volume":"43","author":"Verbrugge","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib6","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/eurheartj\/ehac121","article-title":"BNP: biomarker not perfect in heart failure with preserved ejection fraction","volume":"43","author":"Shah","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ejhf.2377","article-title":"Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity","volume":"24","author":"Obokata","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib8","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiologic targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.01.049_bib9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A\u00a0contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib10","first-page":"678","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ejhf.1091","article-title":"Predictors and outcomes of heart failure with mid-range ejection fraction","volume":"20","author":"Bhambhani","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2021.08.020","article-title":"Trends in heart failure hospitalizations in the US from 2008 to 2018","volume":"28","author":"Clark","year":"2022","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib14","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.117.031622","article-title":"Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction","volume":"137","author":"Pandey","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCULATIONAHA.117.027551","article-title":"Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005-2014): ARIC Study Community Surveillance","volume":"138","author":"Chang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib18","doi-asserted-by":"crossref","first-page":"e003116","DOI":"10.1161\/CIRCHEARTFAILURE.115.003116","article-title":"Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes","volume":"9","author":"Ho","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib19","first-page":"701","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","article-title":"Relationship between physical activity, body mass index, and risk of heart failure","volume":"69","author":"Pandey","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s44161-021-00005-5","article-title":"Identification of patients with preclinical heart failure with preserved ejection fraction using the H2FPEF score","volume":"1","author":"Koepp","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.01.049_bib22","first-page":"640","article-title":"Application of diagnostic algorithms for heart failure with preserved ejection fraction to the community","volume":"8","author":"Selvaraj","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib23","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of death in heart failure with preserved ejection fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4330\/wjc.v14.i9.473","article-title":"Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database","volume":"14","author":"Jha","year":"2022","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008597","article-title":"Mode of death in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF trial","volume":"14","author":"Desai","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004457","article-title":"Racial differences in characteristics and outcomes of patients with heart failure and preserved ejection fraction in the treatment of preserved cardiac function heart failure trial","volume":"11","author":"Lewis","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.122.062832","article-title":"Sex differences in characteristics, outcomes and treatment response with dapagliflozin across\u00a0the range of ejection fraction in patients\u00a0with heart failure: insights from DAPA-HF and DELIVER","volume":"147","author":"Wang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib30","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib31","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib32","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41569-020-00465-5","article-title":"Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging","volume":"18","author":"Ng","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.01.049_bib36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2021.07.014","article-title":"Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC STATE-OF-THE-ART REVIEW","volume":"78","author":"Pandey","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib37","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","article-title":"From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited","volume":"128","author":"Paulus","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.01.049_bib38","first-page":"712","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.122.059280","article-title":"Characteristics of heart failure with preserved ejection fraction across the range of left ventricular ejection fraction","volume":"146","author":"Rosch","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib40","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase g activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib45","first-page":"574","article-title":"The role of the pericardium in heart failure: implications for pathophysiology and treatment","volume":"7","author":"Borlaug","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib46","first-page":"489","article-title":"Impact of general and central adiposity on ventricular-arterial aging in women and men","volume":"2","author":"Wohlfahrt","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.CIR.56.4.605","article-title":"Prediction of the normal blood volume. Relation of blood volume to body habitus","volume":"56","author":"Feldschuh","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cardfail.2019.09.010","article-title":"Impact of obesity on volume status in patients with ambulatory chronic heart failure","volume":"26","author":"Miller","year":"2020","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib49","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2254","article-title":"Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction","volume":"23","author":"Sorimachi","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib50","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.120.052414","article-title":"Reduced right ventricular sarcomere contractility in heart failure with preserved ejection fraction and severe obesity","volume":"143","author":"Aslam","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib51","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib52","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.121.054858","article-title":"Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction","volume":"144","author":"Burrage","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib53","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.119.042770","article-title":"Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response","volume":"141","author":"Rayner","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib55","first-page":"657","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib56","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.01.049_bib57","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib58","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib59","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/jama.2020.16641","article-title":"Effect of praliciguat on peak rate of oxygen consumption in patients with heart failure with preserved ejection fraction: the CAPACITY HFpEF randomized clinical trial","volume":"324","author":"Udelson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib60","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction","volume":"17","author":"Sanders-van Wijk","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib62","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib65","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.1671","article-title":"Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"22","author":"Yang","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib67","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib68","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib69","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib70","article-title":"Circulating vascular cell adhesion molecule-1 and incident heart failure: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"9","author":"Patel","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.01.049_bib71","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2020.02.060","article-title":"Cellular adhesion molecules in young adulthood and cardiac function in later life","volume":"75","author":"Patel","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2023.01.049_bib73","first-page":"999","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib74","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ejhf.2563","article-title":"Sex and central obesity in heart failure with preserved ejection fraction","volume":"24","author":"Sorimachi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib75","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib76","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib77","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/hrt.2010.212787","article-title":"Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction","volume":"97","author":"Borlaug","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.01.049_bib78","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib79","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib80","doi-asserted-by":"crossref","first-page":"e003754","DOI":"10.1161\/CIRCIMAGING.115.003754","article-title":"Prognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strain","volume":"9","author":"Freed","year":"2016","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.jacc.2023.01.049_bib81","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.1464","article-title":"Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction","volume":"21","author":"Reddy","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib82","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ejhf.1399","article-title":"Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction","volume":"21","author":"Telles","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib83","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.120.051542","article-title":"Exercise stress real-time cardiac magnetic resonance imaging for noninvasive characterization of heart failure with preserved ejection fraction: the HFpEF-Stress trial","volume":"143","author":"Backhaus","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib84","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/CIRCULATIONAHA.119.045409","article-title":"Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney","volume":"142","author":"Verbrugge","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib85","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ejhf.2747","article-title":"Central hemodynamic abnormalities and outcome in patients with unexplained dyspnea","volume":"25","author":"Omote","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib87","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib88","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/CIRCULATIONAHA.117.031608","article-title":"Global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction","volume":"137","author":"Fayyaz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib89","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/eurheartj\/ehac184","article-title":"Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications","volume":"43","author":"Omote","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib90","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction","volume":"35","author":"Melenovsky","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib91","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/eurheartj\/ehy809","article-title":"Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction","volume":"40","author":"Obokata","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib92","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","article-title":"Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure","volume":"145","author":"Borlaug","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacc.2019.10.048","article-title":"Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort","volume":"75","author":"Ho","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib94","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib95","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/CIRCULATIONAHA.121.058592","article-title":"Longitudinal evolution of cardiac dysfunction in heart failure and preserved ejection fraction with normal natriuretic peptide levels","volume":"146","author":"Sorimachi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib96","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardfail.2021.10.019","article-title":"Arterial stiffness and vascular load in HFpEF: differences among women and men","volume":"28","author":"Lau","year":"2022","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","article-title":"Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction","volume":"70","author":"Reddy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib98","doi-asserted-by":"crossref","first-page":"H1364","DOI":"10.1152\/ajpheart.00004.2014","article-title":"Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"306","author":"Kitzman","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCULATIONAHA.117.029058","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis","volume":"137","author":"Houstis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib100","first-page":"490","article-title":"Impaired pulmonary diffusion in heart failure with preserved ejection fraction","volume":"4","author":"Olson","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction","volume":"58","author":"Haykowsky","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib102","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006331","article-title":"Mechanisms of chronotropic incompetence in heart failure with preserved ejection fraction","volume":"13","author":"Sarma","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib103","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.jacc.2022.02.050","article-title":"Venous tone and stressed blood volume in heart failure: JACC review topic of the week","volume":"79","author":"Fudim","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hfc.2021.02.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction","volume":"17","author":"Sorimachi","year":"2021","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacc.2023.01.049_bib106","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/CIRCULATIONAHA.119.041818","article-title":"Deliberating the diagnostic dilemma of heart failure with preserved ejection fraction","volume":"142","author":"Ho","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib107","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.119.041657","article-title":"Do existing definitions identify subgroup phenotypes or reflect the natural history of heart failure with preserved ejection fraction?","volume":"140","author":"Senni","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib108","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1093\/cvr\/cvac179","article-title":"Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions","volume":"118","author":"Peters","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.01.049_bib109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hfc.2021.12.002","article-title":"Advances in machine learning approaches to heart failure with preserved ejection fraction","volume":"18","author":"Ahmad","year":"2022","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacc.2023.01.049_bib111","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/d41573-022-00158-3","article-title":"Accelerating therapeutic discoveries for heart failure: a new public-private partnership","volume":"21","author":"Shah","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2023.01.049_bib112","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib113","first-page":"386","article-title":"Burden of heart failure signs and symptoms, prognosis, and response to therapy: the PARAGON-HF trial","volume":"9","author":"Jering","year":"2021","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib114","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","author":"Anjan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmg.2018.12.034","article-title":"Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods","volume":"13","author":"Obokata","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.01.049_bib116","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.116.024822","article-title":"Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study","volume":"135","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib117","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A\u00a0simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib118","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart\u00a0Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib119","first-page":"459","article-title":"Hemodynamic assessment in heart failure with preserved ejection fraction","volume":"40","author":"Omote","year":"2022","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacc.2023.01.049_bib120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750","article-title":"Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure","volume":"11","author":"Eisman","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib121","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamacardio.2022.1916","article-title":"Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea","volume":"7","author":"Reddy","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib122","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.chest.2020.08.019","article-title":"A\u00a0fluid challenge test for the diagnosis of occult heart failure","volume":"159","author":"D'Alto","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.01.049_bib123","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008935","article-title":"The value of passive leg raise during right heart catheterization in diagnosing heart failure with preserved ejection fraction","volume":"15","author":"van de Bovenkamp","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/CIRCHEARTFAILURE.114.001731","article-title":"Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure","volume":"8","author":"Andersen","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction","volume":"56","author":"Maeder","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib126","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart\u00a0Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib127","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","article-title":"Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction","volume":"146","author":"Reddy","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib130","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacc.2022.08.738","article-title":"Long-term changes in cardiac structure and function following bariatric surgery","volume":"80","author":"Sorimachi","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib131","first-page":"678","article-title":"Hemodynamic effects of weight loss in obesity: a systematic review and meta-analysis","volume":"7","author":"Reddy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.01.049_bib132","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2014.03.034","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction","volume":"63","author":"Hwang","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib133","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ejhf.2403","article-title":"Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction","volume":"24","author":"Jackson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib134","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib135","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41591-022-01971-4","article-title":"Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER","volume":"28","author":"Jhund","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib136","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in\u00a0the Treatment of Preserved Cardiac Function\u00a0Heart\u00a0Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib138","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib139","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","article-title":"Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials","volume":"8","author":"Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib141","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2020.26812","article-title":"Effect of high-intensity interval training, moderate continuous training, or guideline-based physical activity advice on peak oxygen consumption in patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"325","author":"Mueller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib142","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib143","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2023.0675","article-title":"Rate-adaptive atrial pacing for heart failure with preserved ejection fraction: the RAPID-HF randomized clinical trial","volume":"329","author":"Reddy","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.01.049_bib144","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.01.049_bib145","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/CIRCULATIONAHA.118.036006","article-title":"Pericardiotomy enhances left ventricular diastolic reserve with volume loading in humans","volume":"138","author":"Borlaug","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib146","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007530","article-title":"Sustained improvement in diastolic reserve following percutaneous pericardiotomy in a porcine model of heart failure with preserved ejection fraction","volume":"14","author":"Jain","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib147","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/ejhf.2559","article-title":"Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort","volume":"24","author":"Fudim","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.01.049_bib148","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.01.049_bib149","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2023.01.049_bib150","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1093\/eurheartj\/ehaa478","article-title":"The heavy heart of HFpEF","volume":"41","author":"Borlaug","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.01.049_bib151","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.01.049_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(23)04466-2","article-title":"Natural language processing for adjudication of heart failure in the electronic health record","author":"Cunningham","year":"2023","journal-title":"J Am Coll Cardiol HF"},{"issue":"2","key":"10.1016\/j.jacc.2023.01.049_bib153","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010161","article-title":"A randomized, controlled trial of resistance training added to caloric restriction plus aerobic exercise training in obese heart failure with preserved ejection fraction","volume":"16","author":"Brubaker","year":"2023","journal-title":"Circ Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723050210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723050210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:38:19Z","timestamp":1782491899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723050210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":153,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0735109723050210"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.01.049","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart\u00a0Failure With Preserved Ejection\u00a0Fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}